Major biotech and pharma companies by net income 2026| ��ƽ��

Leading global biotech and pharmaceutical companies in 2026, by net income (in billion U.S. dollars)

Characteristic	Profits in billion U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

February 2026

More information

Region

Worldwide

Survey time period

as of February 2026

Supplementary notes

Release date represents the date figures were accessed. The source gives no information if data is based on financial year, calendar year, or moving annual total, nor about used exchange rates. Values can include non-pharma/biotech net income, if a company has a diversified business (e.g., Johnson & Johnson).

Citation formats

As of February 2026, the American-based company Johnson & Johnson was the leading biotech and pharmaceutical company with a net income of **** billion U.S. dollars. Eli Lilly followed with a net income of about 21 billion dollars.

Biotech and pharmaceutical companies

Johnson & Johnson and Eli Lilly, both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately **** billion U.S. dollars and billion U.S. dollars, respectively, as of 2026. Johnson & Johnson generated some **** billion U.S. dollars of revenue in 2024. Pfizer had record-high annual revenues during the COVID-19 vaccination campaign, exceeding 100 billion U.S. dollars in 2022.

Story of a former blockbuster

Lyrica was once one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some **** billion U.S. dollars in revenue.